Kristin Brooks, Contract Pharma10.28.19
Unimaginable innovation in drug development has led to more complex and increasingly targeted therapies for smaller patient populations, particularly in the rare and orphan disease space. In clinical research, this translates into challenges, such as logistics and patient recruitment, that require global operations, advanced analytics, data and communications capabilities and scientific expertise.
Contract Research Organizations (CROs) have grown into a global industry these past 20 years, offering services across the drug discovery and development continuum. From their clinical origins, CROs have since added lab services, regulatory consulting, data capture and analytics platforms, as well as scale, all with the goal of helping sponsors to advance their drug development programs, make go/no-go decisions faster, provide critical information and quality data in real-time.
Randy Marchbanks, Senior Vice President, global development operations at PPD, discusses how
FREE SUBSCRIPTION
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
